Nuvation Bio Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NUVB, NUVB-WT on NYSE
Industry
Pharmaceutical Preparations
Location
357 Tehama Street, Floor 3, San Francisco, California

Insiders trading volume in the past year

Nuvation Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Omega Fund V, L.P. 10%+ Owner $115M Apr 5, 2022
Xiangmin Cui Director $77.1M +$2.32M +3.1% Sep 3, 2024
Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director $18.3M Sep 3, 2024
Oleg Nodelman Director $17.3M +$6.69M +63.4% Sep 19, 2023
Daniel G. Welch Director $1.08M May 24, 2024
Kim D. Blickenstaff Director $500K +$500K Sep 3, 2024
Moses Makunje Title: VP, Finance and principal financial and accounting officer. $340K Feb 29, 2024
Colleen Sjogren Chief Commercial Officer $34K Apr 9, 2024
David C. Hanley Chief Technical Operations $16.3K Feb 29, 2024
Stacy Markel Chief People Officer $14.4K Feb 29, 2024
Dongfang Liu Chief Medical Officer $8.17K Feb 29, 2024
Jennifer A. Fox Chief Financial Officer $6.1K Feb 28, 2023
W. Anthony Vernon Director Sep 3, 2024
Robert Mashal Director Jan 8, 2024
Kathryn E. Falberg Director Sep 3, 2024
Kerry Wentworth Chief Regulatory Officer Feb 29, 2024
Hung David PRESIDENT AND CEO, Director, 10%+ Owner Feb 29, 2024
Robert B. Bazemore Director Sep 3, 2024
Gary Hattersley Chief Scientific Officer Feb 29, 2024

Recent Insider Transactions by Companies or Individuals for Nuvation Bio Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.